The cancer specialists are asking big pharmaceutical companies to reduce prices for some drugs. Since 2000, the prices have been increased by $8,500 per year.
They demanded the price cut in an article written against big pharmaceutical companies that are mainly coming up with market prices.
The doctors are pointing out the prices as a result of the fact that it creates problem in the treatment in addition to general care of patients suffering from cancer who cannot manage to pay large amounts. Because of this, many patients look for costly loans and it further causes stress and financial problems.
As per data that has been put forward in the article, people who have the average $52,000 per year household income in the country would not have sufficient money to bear even 50% of the costs of some costly treatments.
It has been reported that the 118 cancer specialists have come up with the article in order to talk about Medicare-related drugs with big pharmaceutical companies.
According to PhRMA spokesman Robert Zirkelbach, “The article ignores the fact that cancer medicines represent only one-fifth of total spending on cancer treatment. The policy proposals they recommend would send a chilling signal to the marketplace that risk-taking will no longer be rewarded”. He said it will also stop modernization in its tracks and will put an end to decades of development in cancer care.
Return to News Home
